Onset and duration of effect of incobotulinumtoxinA, onabotulinumtoxinA, and abobotulinumtoxinA in the treatment of glabellar frown lines: a randomized, double-blind study

BACKGROUND: Three botulinum neurotoxin type A preparations (incobotulinumtoxinA, onabotulinumtoxinA, and abobotulinumtoxinA) are widely approved in Europe and in the US for the treatment of glabellar frown lines. The purpose of this study was to determine and compare the time to onset and duration o...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Rappl, Thomas, Parvizi, Daryousch, Friedl, Herwig, Wiedner, Maria, May, Simone, Kranzelbinder, Bettina, Wurzer, Paul, Hellbom, Bengt
Formato: Artigo
Idioma:Inglês
Publicado: Dove Medical Press 2013
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3789632/
https://ncbi.nlm.nih.gov/pubmed/24098087
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CCID.S41537
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares